Melanotan-2: What the Evidence Actually Shows

Grade CFDA has warned about this

This one has documented harm

FDA has issued repeated public warnings about melanotan-2. Reported effects include nausea and vomiting, blood pressure changes, spontaneous erections, and darkening and change in existing moles. Case reports have described new or changed melanocytic lesions in users, and at least some have described melanoma diagnosed in the context of use.

We are not going to soften that. This is the compound on the list where the risk is clearest and the benefit is purely cosmetic.

The short version

A synthetic melanocortin receptor agonist that stimulates melanin production.
Used for tanning without sun exposure, and sometimes for libido effects.
Not approved anywhere for this use.
Non-selective across melanocortin receptors, which is why the side effect list is long.
Documented effects on moles are the reason dermatologists raise this specifically.

The receptor problem

Melanotan-2 activates several melanocortin receptor subtypes rather than one. MC1R gives the pigmentation. MC4R involvement produces the sexual and appetite effects. That lack of selectivity is the whole reason the side effect profile is what it is, and it is not a formulation issue that a better supplier can solve.

The mole issue, specifically

A compound that stimulates melanocytes systemically will act on all of them, including any that are already atypical. Users report existing moles darkening and new pigmented lesions appearing. That matters because it makes melanoma surveillance harder at exactly the moment it becomes more important. If you have used this, tell your dermatologist.

What this will not do

It will not protect you from UV damage. Induced pigmentation is not equivalent sun protection.
It will not be legally available.

Full library · Safety and sourcing · Reconstitution calculator · Compound index